These panels usually contain established breast cancer susceptibility genes, such as BRCA1, BRCA2, PALB2, TP53, CHEK2, and ATM, and potential breast cancer susceptibility genes, such as BARD1, BRIP1, RAD50, RAD51C, and RAD51D5,6. This evidence concerns the gene BARD1 and breast carcinoma.